Home › NDC Lookup › RxCUI directory › RxCUI 1989085

Bosentan 32 MG Tablet for Oral Suspension [Tracleer] — RxCUI 1989085

RxNorm drug concept · Semantic branded drug
RxCUI 1989085 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1989085
Official nameBosentan 32 MG Tablet for Oral Suspension [Tracleer]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTracleer 32 MG Tablet for Oral Suspension
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)676 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bosentan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pulmonary arterial hypertension, or PAH, means the blood pressure inside the arteries in your lungs is dangerously high. That forces your heart to work much harder than it should....
  • What exactly is bosentan treating — what's wrong with my lungs?
  • Please don't skip them — this is one of the most important parts of being on bosentan. The drug can raise liver enzyme levels, which is a sign of stress on your liver, and this can...
  • Why do I need a blood test every single month? Can I skip one if I feel fine?
📖 Read our full Bosentan guide →

🕸️ Concept Web — How Bosentan 32 MG Tablet for Oral Suspension [Tracl... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bosentan 32 MG Tablet for Oral Suspension [Tracleer] RxCUI 1989085

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bosentan 75207
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tracleer 323502
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bosentan Tablet for Oral Suspension 1989080
    • Bosentan Oral Liquid Product 1989079
    • Bosentan Oral Product 1163076
    • Bosentan Tablet for Oral Suspension [Tracleer] 1989083
    • Tracleer Oral Liquid Product 1989084
    • Tracleer Oral Product 1178626
    • Tablet for Oral Suspension 1861409
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bosentan 32 MG Tablet for Oral Suspension SCD · 1989081
  • Bosentan 32 MG SCDC · 1989078
  • Bosentan Tablet for Oral Suspension SCDF · 1989080
  • Bosentan Oral Liquid Product SCDG · 1989079
  • Bosentan Oral Product SCDG · 1163076

Brand-Name Concepts

  • Bosentan 32 MG [Tracleer] SBDC · 1989082
  • Bosentan Tablet for Oral Suspension [Tracleer] SBDF · 1989083
  • Tracleer Oral Liquid Product SBDG · 1989084
  • Tracleer Oral Product SBDG · 1178626
  • Tracleer BN · 323502

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 1989085 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
66215-0101-03 10 BLISTER PACK in 1 CARTON (66215-101-03) / 3 TABLET, FILM... Tracleer Actelion Pharmaceuticals US, Inc. 2012-10-02
66215-0101-06 1 BOTTLE, PLASTIC in 1 CARTON (66215-101-06) / 60 TABLET, F... Tracleer Actelion Pharmaceuticals US, Inc. 2001-11-20
66215-0102-03 10 BLISTER PACK in 1 CARTON (66215-102-03) / 3 TABLET, FILM... Tracleer Actelion Pharmaceuticals US, Inc. 2012-10-02
66215-0102-06 1 BOTTLE, PLASTIC in 1 CARTON (66215-102-06) / 60 TABLET, F... Tracleer Actelion Pharmaceuticals US, Inc. 2001-11-20
66215-0232-56 4 BLISTER PACK in 1 CARTON (66215-232-56) / 14 TABLET, FOR... Tracleer Actelion Pharmaceuticals US, Inc. 2021-07-29
Observed labelers: Actelion Pharmaceuticals US, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.